Product NDC: | 0781-3113 |
Proprietary Name: | Piperacillin and Tazobactam |
Non Proprietary Name: | Piperacillin and Tazobactam |
Active Ingredient(s): | 3; .375 g/15mL; g/15mL & nbsp; Piperacillin and Tazobactam |
Administration Route(s): | INTRAVENOUS; PARENTERAL |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-3113 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065362 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101021 |
Package NDC: | 0781-3113-95 |
Package Description: | 10 VIAL, SINGLE-USE in 1 CARTON (0781-3113-95) > 15 mL in 1 VIAL, SINGLE-USE (0781-3113-90) |
NDC Code | 0781-3113-95 |
Proprietary Name | Piperacillin and Tazobactam |
Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (0781-3113-95) > 15 mL in 1 VIAL, SINGLE-USE (0781-3113-90) |
Product NDC | 0781-3113 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Piperacillin and Tazobactam |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS; PARENTERAL |
Start Marketing Date | 20101021 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc |
Substance Name | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
Strength Number | 3; .375 |
Strength Unit | g/15mL; g/15mL |
Pharmaceutical Classes | beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |